Latest news with #PICOIV
Yahoo
4 days ago
- Business
- Yahoo
PICO IV Announces Strategic Partnership with Liquivida, Names Sam Tejada as Spokesperson
SACRAMENTO, Calif., Aug. 15, 2025 /PRNewswire/ -- PICO IV, the pioneers behind the world's first sterile CBD emulsion, have announced a strategic partnership with Liquivida®, a national leader in IV therapy and wellness. This partnership marks an exciting turn for both companies as they continue to innovate in IV hydration while upholding the highest standards of safety and education. As part of the partnership, Liquivida founder and wellness pioneer Sam Tejada, who also serves as Chairman of the Leadership Advisory Board for the American IV Association (AIVA), has been appointed to the PICO IV Advisory Board. As a spokesperson for the brand, Tejada will help raise awareness about the clinical potential of CBD and the importance of understanding the body's endocannabinoid system (ECS), a complex regulatory network that plays a vital role in the body's overall balance and regulation. "This isn't just a new product, it's the beginning of a new category of treatment," said Tejada. "At Liquivida, we're deeply selective about what we bring into our clinics, and PICO IV meets the highest standards of safety, science, and purpose. We're excited about what this means for the future of IV therapy and the health of our patients." While oral and topical CBD products have enjoyed a significant boom, especially since the passing of the Farm Bill in 2018, these delivery methods have limitations, as only a portion of the CBD is absorbed by the body. With PICO IV's patent-pending technology, the company has reduced the size of the CBD particle to its lowest point: the pico realm, a step below nano. This reduction in particle size allows the CBD to pass through a sterile filter while also allowing for more efficient absorption, resulting in nearly 100% bioavailability. These advancements in CBD technology support more precise dosing and rapid systemic effects, which can be especially meaningful in clinical or performance-based settings. PICO IV is the first and only CBD to be made into a sterile solution. It is manufactured in a cGMP facility, undergoes rigorous batch testing, and is sterilized using e-beam technology—a proven method that eliminates contaminants without compromising product integrity. The company's commitment to safety and purity is unmatched. "With our sterile CBD being so new to the market, we understand the opportunity ahead of us," said Joe Young, Chief Executive Officer at PICO IV. "That's why our top priority has always been safety. We've taken extraordinary care to ensure this product can be trusted throughout every step in our manufacturing process." A major goal of the partnership is to increase provider awareness of the ECS, which, despite being essential to human health, remains underrepresented in conventional medical education. As the science continues to progress, and through ongoing evaluations of patient care and outcomes, Liquivida will play a key role in educating its nationwide network of affiliate doctors and the patients of their affiliate doctors about the ECS, the science behind sterile CBD, and the responsible integration of PICO IV into clinical and wellness protocols. The partnership comes at a pivotal moment for both companies, as interest in advanced wellness tools continues to grow and more providers seek evidence-based options that bridge natural medicine and clinical rigor. This collaboration ensures that those solutions are not only accessible but also grounded in science. About PICO IV PICO IV is the creator of the world's first sterile CBD solution. Developed using patent-pending technology and utilizing FDA-approved filtration standards. PICO IV's flagship formula delivers cannabinoids with unmatched purity and precision. For more information, visit About Liquivida Liquivida® is a premier wellness franchise where science and self-care meet, offering IV therapy, weight loss, hormone and sexual health programs, regenerative therapies, and aesthetics to help people thrive. Through science-backed, personalized care, Liquivida® targets the root causes of health concerns — so people from all walks of life can live longer, stronger, and healthier. For more information, visit For media inquiries please contact mfox@ View original content to download multimedia: SOURCE PicoIV
Yahoo
19-05-2025
- Health
- Yahoo
PICO IV's Presence at MAHA Gala Marks Growing Legitimacy for CBD in Holistic Healthcare
JUPITER, Fla., May 19, 2025 /PRNewswire/ -- PICO IV, the company behind the world's first sterile CBD solution designed to support the endocannabinoid system, joined healthcare innovators, wellness leaders, and forward-thinking organizations at the MAHA Spring Gala in Jupiter, Florida. The event, hosted by MAHA Action, marks a monumental moment for the CBD company, representing a broader shift in thinking regarding natural therapies and CBD's role in modern healthcare. A Growing Movement for Health Reform Led by CEO Del Bigtree, MAHA Action is a 501(c)(4) organization and a national movement committed to tackling the chronic disease epidemic through greater transparency, informed consent, and science-backed public health reform. This year's Spring Gala featured thought leaders like Del Bigtree, Alex Clark, and Sayer Ji, as well as organic food, live music, and a shared vision for a healthier America. A Sign of Progress for Natural Therapies "Being part of the MAHA Spring Gala was an incredible honor. We're proud to be alongside other innovators who are working to improve healthcare," said Joe Young, CEO and Co-Founder of PICO IV. "The fact that a CBD company was welcomed into this conversation signals just how far the wellness and healthcare space has evolved, and where it's headed." Looking Ahead As MAHA Action continues to rally the healthcare disruptors of tomorrow, PICO IV is proud to stand among those innovating and offering natural solutions to today's healthcare landscape. About PICO IVPICO IV is the creator of the world's first sterile CBD solution. Developed using patent-pending technology and utilizing FDA-approved filtration standards. PICO IV's flagship formula delivers cannabinoids with unmatched purity and precision. For more information, visit Contact:Maegan McCarthy FoxMfox@ View original content to download multimedia: SOURCE PicoIV Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
